Oral or intravenous iron for anemia correction in chronic kidney disease?

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Iron deficiency in patients with chronic kidney disease (CKD) can be corrected by the oral or intravenous route. The natural intestinal barrier against iron overload is circumvented by intravenous iron. The balance between benefit and risk of high iron doses remains unclear. In a randomized controlled trial in CKD patients, Agarwal et al. find similar effects of oral and intravenous iron on hemoglobin levels and kidney function decline but more serious cardiovascular events and infections with intravenous iron.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Kidney Int.

Title: Kidney international

ISSN (Electronic): 1523-1755

ISSN (Print): 0085-2538

Publication date (Electronic): Oct 2015

Volume: 88

Issue: 4

Affiliations

[1 ] Inserm MRS Unité 1018, Team 5, Hôpital Paul Brousse, Paris-Sud University and Versailles Saint-Quentin-en-Yvelines University (Paris-Ile-de-France-Ouest University), Villejuif, France.

[2 ] Division of Nephrology, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris, Versailles Saint-Quentin-en-Yvelines University (Paris-Ile-de-France-Ouest University), Boulogne Billancourt/Paris, France.

Article

Publisher Item ID: S2157-1716(15)32256-5

DOI: 10.1038/ki.2015.189

PubMed ID: 26422625

SO-VID: 6ea0f38c-7d47-4ada-a625-7eecb1cac607

History

Data availability:

Comments

Comment on this article

scite_

Cited by 6

See all cited by

- Version 1